Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Pseudoephedrine, PPA reporting exemption

This article was originally published in The Tan Sheet

Executive Summary

Pseudoephedrine, PPA reporting exemption: Drug Enforcement Administration publishes interim rule Oct. 17 providing a temporary exemption from chemical registration requirements to the distributors of pseudoephedrine and phenylpropanolamine products. Registration requirements for distributors of pseudoephedrine and PPA are effective Oct. 3 under the Comprehensive Methamphetamine Control Act. Those required by the law to register with DEA in order to handle pseudoephedrine and PPA products must submit an application by Dec. 3 in order to continue distribution until final action has been taken on the application. Comments on the exemption are due Dec. 16. In a separate, same-day notice, DEA announces it is waiving a portion of the registration fee for non-retail distributors of pseudoephedrine, PPA and combination ephedrine drugs, effective immediately...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087669

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel